SRS16155386 SAMN25943226 2705-CLL1_T1 CLL1_T1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id CLL1_T1 submitted sample id CLL1_T1 submitted subject id CLL1 gap_sample_id 4862954 gap_subject_id 3862243 sex male body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155387 SAMN25943243 2705-CLL1_T2 CLL1_T2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id CLL1_T2 submitted sample id CLL1_T2 submitted subject id CLL1 gap_sample_id 4862955 gap_subject_id 3862243 sex male body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155388 SAMN25943228 2705-CLL2_T1 CLL2_T1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id CLL2_T1 submitted sample id CLL2_T1 submitted subject id CLL2 gap_sample_id 4862956 gap_subject_id 3862244 sex female body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155389 SAMN25943247 2705-CLL2_T2 CLL2_T2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id CLL2_T2 submitted sample id CLL2_T2 submitted subject id CLL2 gap_sample_id 4862957 gap_subject_id 3862244 sex female body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155390 SAMN25943236 2705-CLL3_T1 CLL3_T1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id CLL3_T1 submitted sample id CLL3_T1 submitted subject id CLL3 gap_sample_id 4862958 gap_subject_id 3862245 sex male body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155391 SAMN25943252 2705-CLL3_T2 CLL3_T2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id CLL3_T2 submitted sample id CLL3_T2 submitted subject id CLL3 gap_sample_id 4862959 gap_subject_id 3862245 sex male body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155392 SAMN25943230 2705-CLL4_T1 CLL4_T1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id CLL4_T1 submitted sample id CLL4_T1 submitted subject id CLL4 gap_sample_id 4862960 gap_subject_id 3862246 sex female body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155393 SAMN25943225 2705-CLL4_T2 CLL4_T2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id CLL4_T2 submitted sample id CLL4_T2 submitted subject id CLL4 gap_sample_id 4862961 gap_subject_id 3862246 sex female body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155394 SAMN25943231 2705-CLL5_T1 CLL5_T1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id CLL5_T1 submitted sample id CLL5_T1 submitted subject id CLL5 gap_sample_id 4862962 gap_subject_id 3862247 sex male body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155395 SAMN25943238 2705-CLL5_T2 CLL5_T2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id CLL5_T2 submitted sample id CLL5_T2 submitted subject id CLL5 gap_sample_id 4862963 gap_subject_id 3862247 sex male body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155396 SAMN25943227 2705-CLL6_T1 CLL6_T1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id CLL6_T1 submitted sample id CLL6_T1 submitted subject id CLL6 gap_sample_id 4862964 gap_subject_id 3862248 sex male body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155397 SAMN25943245 2705-CLL6_T2 CLL6_T2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id CLL6_T2 submitted sample id CLL6_T2 submitted subject id CLL6 gap_sample_id 4862965 gap_subject_id 3862248 sex male body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155398 SAMN25943248 2705-CLL7_T1 CLL7_T1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id CLL7_T1 submitted sample id CLL7_T1 submitted subject id CLL7 gap_sample_id 4862966 gap_subject_id 3862249 sex female body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155399 SAMN25943229 2705-CLL7_T2 CLL7_T2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id CLL7_T2 submitted sample id CLL7_T2 submitted subject id CLL7 gap_sample_id 4862967 gap_subject_id 3862249 sex female body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155400 SAMN25943234 2705-HD1 HD1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id HD1 submitted sample id HD1 submitted subject id HD1 gap_sample_id 4862968 gap_subject_id 3862250 body site Peripheral blood histological type Healthy donor analyte type PBMC is tumor No gap_consent_code 1 gap_consent_short_name HMB SRS16155401 SAMN25943241 2705-HD2 HD2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id HD2 submitted sample id HD2 submitted subject id HD2 gap_sample_id 4862969 gap_subject_id 3862251 body site Peripheral blood histological type Healthy donor analyte type PBMC is tumor No gap_consent_code 1 gap_consent_short_name HMB SRS16155402 SAMN25943249 2705-MBL-CLL1_T1 MBL-CLL1_T1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id MBL-CLL1_T1 submitted sample id MBL-CLL1_T1 submitted subject id MBL-CLL1 gap_sample_id 4862970 gap_subject_id 3862252 sex male body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155403 SAMN25943251 2705-MBL-CLL1_T2 MBL-CLL1_T2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id MBL-CLL1_T2 submitted sample id MBL-CLL1_T2 submitted subject id MBL-CLL1 gap_sample_id 4862971 gap_subject_id 3862252 sex male body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155404 SAMN25943233 2705-MBL-CLL2_T1 MBL-CLL2_T1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id MBL-CLL2_T1 submitted sample id MBL-CLL2_T1 submitted subject id MBL-CLL2 gap_sample_id 4862972 gap_subject_id 3862253 sex female body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155405 SAMN25943244 2705-MBL-CLL2_T2 MBL-CLL2_T2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id MBL-CLL2_T2 submitted sample id MBL-CLL2_T2 submitted subject id MBL-CLL2 gap_sample_id 4862973 gap_subject_id 3862253 sex female body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155406 SAMN25943253 2705-MBL-CLL3_T1 MBL-CLL3_T1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id MBL-CLL3_T1 submitted sample id MBL-CLL3_T1 submitted subject id MBL-CLL3 gap_sample_id 4862974 gap_subject_id 3862254 sex female body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155407 SAMN25943240 2705-MBL-CLL3_T2 MBL-CLL3_T2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id MBL-CLL3_T2 submitted sample id MBL-CLL3_T2 submitted subject id MBL-CLL3 gap_sample_id 4862975 gap_subject_id 3862254 sex female body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155408 SAMN25943246 2705-MBL-CLL4_T1 MBL-CLL4_T1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id MBL-CLL4_T1 submitted sample id MBL-CLL4_T1 submitted subject id MBL-CLL4 gap_sample_id 4862976 gap_subject_id 3862255 sex male body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155409 SAMN25943232 2705-MBL-CLL4_T2 MBL-CLL4_T2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id MBL-CLL4_T2 submitted sample id MBL-CLL4_T2 submitted subject id MBL-CLL4 gap_sample_id 4862977 gap_subject_id 3862255 sex male body site Peripheral blood histological type Chronic lymphocytic leukemia analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155410 SAMN25943242 2705-MBL1_T1 MBL1_T1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id MBL1_T1 submitted sample id MBL1_T1 submitted subject id MBL1 gap_sample_id 4862978 gap_subject_id 3862256 sex female body site Peripheral blood histological type Monoclonal B lymphocytosis analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155411 SAMN25943235 2705-MBL1_T2 MBL1_T2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id MBL1_T2 submitted sample id MBL1_T2 submitted subject id MBL1 gap_sample_id 4862979 gap_subject_id 3862256 sex female body site Peripheral blood histological type Monoclonal B lymphocytosis analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155412 SAMN25943239 2705-MBL2_T1 MBL2_T1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id MBL2_T1 submitted sample id MBL2_T1 submitted subject id MBL2 gap_sample_id 4862980 gap_subject_id 3862257 sex male body site Peripheral blood histological type Monoclonal B lymphocytosis analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155413 SAMN25943250 2705-MBL2_T2 MBL2_T2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id MBL2_T2 submitted sample id MBL2_T2 submitted subject id MBL2 gap_sample_id 4862981 gap_subject_id 3862257 sex male body site Peripheral blood histological type Monoclonal B lymphocytosis analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155414 SAMN25943224 2705-MBL3_T1 MBL3_T1 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id MBL3_T1 submitted sample id MBL3_T1 submitted subject id MBL3 gap_sample_id 4862982 gap_subject_id 3862258 sex male body site Peripheral blood histological type Monoclonal B lymphocytosis analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB SRS16155415 SAMN25943237 2705-MBL3_T2 MBL3_T2 9606 Homo sapiens gap_accession phs002705 submitter handle NCI_CLL_Reversal_Ibrutinib biospecimen repository NCI_CLL_Reversal_Ibrutinib study name Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib study design Collection biospecimen repository sample id MBL3_T2 submitted sample id MBL3_T2 submitted subject id MBL3 gap_sample_id 4862983 gap_subject_id 3862258 sex male body site Peripheral blood histological type Monoclonal B lymphocytosis analyte type PBMC is tumor Yes gap_consent_code 1 gap_consent_short_name HMB